Tag: Seres
Seres Therapeutics and Nestlé Health Science Present Late-Breaking Data on VOWST…...
– Post-hoc analysis results with VOWST highlight the importance of gut microbiome diversity as a critical component of a treatment regimen to reduce...
Seres Therapeutics Presents Phase Ill Results of SER-109 for Recurrent C....
– In ECOSPOR lll, Seres' lead therapeutic candidate incorporated itself rapidly and durably into the microbiome to prevent C. difficile infection recurrence –
–...